BioPlus Acquisition Corp.

BioPlus Acquisition Corp. (Nasdaq: BIOS) is a blank check company formed to pursue a business combination in the healthcare and life sciences sector. The company filed an 8-K with the SEC on October 4, 2023, accession number 0001013762-23-001374, reflecting continued activity in its post-IPO search phase. BioPlus targets opportunities across the broader biotech and healthcare services landscape, consistent with its sector mandate. The SPAC remains a tracked name for investors monitoring life sciences deal flow through the blank check market. Sign up at SpacDesk for full filing history, sponsor details, timeline analytics, and real-time alerts on BioPlus Acquisition Corp. and hundreds of other active SPACs.